Krystal Biotech KRYS
NASDAQ KRYS
$322.28 -3.03 (-0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Krystal Biotech (KRYS) Return on Assets [ROA] (2017 - 2026)

Updated

Krystal Biotech (KRYS) posted Return on Assets [ROA] of 16.67% for Q2 2026, up 3.41 percentage points from 13.26% a year earlier and up 0.19 percentage points from the prior quarter.

Analysis

Krystal Biotech (KRYS) Return on Assets [ROA] (2017 - 2026) Analysis & Trends

For FY2025, Krystal Biotech's Return on Assets [ROA] came in at 17.14%, up 7.63 percentage points from FY2024.

  • Annual Return on Assets [ROA] has increased for three consecutive years, with a five-year change of +29.84 percentage points (FY2020 to FY2025).
  • In prior years, Krystal Biotech's Return on Assets [ROA] was 9.51% in FY2024 (+7.93 pp), 1.59% in FY2023 (+25.22 pp), -23.63% in FY2022 (-8.78 pp) and -14.85% in FY2021 (-2.15 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -26.38% in Q1 2023 to a high of 16.73% in Q3 2025 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last 12 quarters, with an average year-over-year change of +6.37 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2024, with a gain of 36.35 percentage points; the weakest was Q4 2022, with a drop of 12.64 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 16.48% (Q1 2026), 15.91% (Q4 2025) and 16.73% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Krystal Biotech 9.54 Bn 6.31 Bn 112.79 Mn 16.67%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.67%
Mar 31, 2026 16.48%
Dec 31, 2025 15.91%
Sep 30, 2025 16.73%
Jun 30, 2025 13.26%
Mar 31, 2025 11.64%
Dec 31, 2024 8.75%
Sep 30, 2024 5.51%
Jun 30, 2024 11.96%
Mar 31, 2024 6.84%
Dec 31, 2023 0.92%
Sep 30, 2023 -4.89%
Jun 30, 2023 -24.39%
Mar 31, 2023 -26.38%
Dec 31, 2022 -25.59%
Sep 30, 2022 -22.47%
Jun 30, 2022 -19.13%
Mar 31, 2022 -16.75%
Dec 31, 2021 -12.95%
Sep 30, 2021 -13.04%
API Access

Krystal Biotech Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KRYS&period=max&api_key=YOUR_API_KEY